US 7351411
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
granted A61KA61K38/00A61P
Quick answer
US patent 7351411 (Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61P, A61P13/12, A61P35/00